Kinetics of SARS-CoV-2 Shedding in Nursing Home Residents and Staff.
Supporting Files
-
July 2025
-
Available in CDC Stacks on July 29, 2025, 12:00 AM
File Language:
English
Details
-
Alternative Title:Journal of the American Geriatrics Society, 2025, v. 73, no. 7: Kinetics of SARS-CoV-2 Shedding in Nursing Home Residents and Staff.
-
Journal Article:Journal of the American Geriatrics Society
-
Personal Author:Katz, Morgan J. ; Reeves, Majerle ; Harris, Tiffany G. ; Duque, Jazmin ; Fridkin, Scott K. ; Rebolledo, Paulina A. ; Furuno, Jon P. ; Short, Emily K. ; Canaday, David H. ; Abul, Yasin ; Gravenstein, Stefan ; Cosgrove, Sara E. ; Mody, Lona ; Meddings, Jennifer ; Nace, David A. ; Handler, Steven ; Crnich, Christopher J. ; Meece, Jennifer ; Webby, Richard J. ; Fabrizio, Tom P. ; Harcourt, Jennifer L. ; Healy, Jessica M. ; Lipsitch, Marc ; Lutgring, Joseph D. ; Paul, Prabasaj ; Zipfel, Casey M. ; Hernandez-Romieu, Alfonso C. ; Reddy, Sujan C. ; Slayton, Rachel B.
-
Description:Nursing homes (NHs) were disproportionately affected by the COVID-19 pandemic. However, little is known regarding the kinetics of SARS-CoV-2 shedding in NH residents and staff, which could inform treatment and infection prevention.
We enrolled NH residents and staff in eight US states from April to November 2023 and analyzed the kinetics of SARS-CoV-2 using serial antigen and molecular (RT-PCR) tests, whole genome sequencing, and viral culture (VC). Symptoms, vaccination, and treatment were collected via interviews and chart review. Viral load trajectories were modeled with gamma distribution functional forms. Antigen and VC test positivity over time were assessed using a Chi-squared test.
Of the 587 enrolled participants, 86 tested positive and 73 underwent testing for ≥ 10 days; most residents (78%) and staff (87%) had ≥ 3 COVID-19 vaccine doses. The modeled SARS-CoV-2 proliferation period (period prior to reaching peak viral load) had ended for 48% (14/29) of residents and 56% (9/16) of staff when they took the initial RT-PCR test. Both antigen and VC showed higher positivity rates early in the course of disease (Days 0-5 vs. Days ≥ 6) (antigen: p < 0·001, VC: p < 0·001). VC positivity was 15% after Day 5 (14/96); two participants were VC positive after Day 10.
Peak viral load occurs early in the disease, suggesting asymptomatic and presymptomatic transmission may be a significant driver of transmission. Only two participants had a positive VC after Day 10, supporting current isolation and return to work recommendations. -
Content Notes:Author manuscript
-
Subjects:
-
Keywords:
-
Source:Journal of the American Geriatrics Society, 2025, v. 73, no. 7
-
DOI:
-
ISSN:0002-8614 ; 1532-5415
-
Pubmed ID:40317518
-
Pubmed Central ID:PMC12303745
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
Pages in Document:2127-2136 (18 pdf pages)
-
Volume:73
-
Issue:7
-
Download URL:
-
File Type:
-
Collection(s):
-
Main Document Checksum:urn:sha-512:fd0befaff7866cc95dcac3d4ebfa0714b2c371651f5552b8c949f5fd058280e041fa979e61e38ff63c398f46d391d74f403edaf2fe85a5524f277bcc728c9e82
Supporting Files
File Language:
English
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings, journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access